
May 22 (Reuters) - DUBAI INVESTMENTS DINV.DU:
GLOBALPHARMA INKS 4 STRATEGIC MOUS TO BOOST PHARMA LOCALIZATION AND INNOVATION IN UAE
AGREEMENTS WERE CONCLUDED WITH PHARMAPRIMES LABORATORIES (JORDAN), NERHADOU INTERNATIONAL (EGYPT), AORA HEALTH
(SPAIN), AND BIOSYENT PHARMA INC. (CANADA)
DUBAI INVESTMENTS - PARTNERSHIPS SPAN AREAS LIKE TECHNOLOGY TRANSFER, PRODUCT LICENSING, SUPPLY, LOCAL MANUFACTURING
COLLABORATIONS AIM TO BOLSTER DOMESTIC PRODUCTION, REDUCE RELIANCE ON IMPORTS